Stocks and Investing
Stocks and Investing
Fri, August 5, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Maintained (AUTL) at Strong Buy with Decreased Target to $12 on, Aug 5th, 2022
Gil Blum of Needham, Maintained "Autolus Therapeutics plc" (AUTL) at Strong Buy with Decreased Target from $13 to $12 on, Aug 5th, 2022.
Gil has made no other calls on AUTL in the last 4 months.
There is 1 other peer that has a rating on AUTL. Out of the 1 peers that are also analyzing AUTL, 0 agree with Gil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gil
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, June 14th, 2022
Contributing Sources